Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms

Jiang Chen; Dan G. Duda

doi:10.1016/j.ebiom.2020.102644

Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Article number	102644
Journal	EBioMedicine
Volume	52
DOIs	https://doi.org/10.1016/j.ebiom.2020.102644
State	Published - Feb 2020

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1016/j.ebiom.2020.102644

Cite this

@article{7d02070ba72946778e545071409c6bf5,

title = "Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms",

author = "Jiang Chen and Duda, \{Dan G.\}",

year = "2020",

month = feb,

doi = "10.1016/j.ebiom.2020.102644",

language = "English (US)",

volume = "52",

journal = "EBioMedicine",

issn = "2352-3964",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Overcoming sorafenib treatment-resistance in hepatocellular carcinoma

T2 - A future perspective at a time of rapidly changing treatment paradigms

AU - Chen, Jiang

AU - Duda, Dan G.

PY - 2020/2

Y1 - 2020/2

UR - https://www.scopus.com/pages/publications/85078662005

UR - https://www.scopus.com/inward/citedby.url?scp=85078662005&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2020.102644

DO - 10.1016/j.ebiom.2020.102644

M3 - Comment/debate

C2 - 32014823

AN - SCOPUS:85078662005

SN - 2352-3964

VL - 52

JO - EBioMedicine

JF - EBioMedicine

M1 - 102644

ER -

Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this